一例头孢曲松诱导的假性胆囊结石及相关文献复习
A Case of Pseudo Gallstones Induced by Ceftriaxone and Related Literature Review
DOI: 10.12677/acm.2024.1461912, PDF,   
作者: 陈 力：青岛大学附属医院消化内科，山东 青岛；顾 鹏：青岛市市立医院消化内科，山东 青岛
关键词: 胆囊结石；头孢曲松；假结石；Gallbladder Stones； Ceftriaxone； Pseudo Gallstones
摘要: 目的：提高临床工作者对头孢曲松致胆囊假性结石的认识，提高医疗质量。方法：对青岛大学附属医院医院1例头孢曲松引起胆囊假性结石的案例进行分析并复习相关文献。结果：患者在连续静脉使用头孢曲松钠(2 g/d) 15天内，因肺部感染复查胸部CT时无意间发现胆囊结石，但患者本身无消化道症状，停用头孢曲松1个月后复查腹部B超胆囊结石消失。结论：头孢曲松致胆囊假性结石的发生率较高，多见于大剂量长疗程使用，大多数患者无症状，因胆囊结石可于1~2个月内自行消失，一般不需要特殊处理。
Abstract: Objective: To enhance the understanding of clinical workers about pseudo gallstones caused by ceftriaxone and improve the quality of medical treatment. Method: A case of pseudo gallstones caused by ceftriaxone in The Affiliated Hospital of Qingdao University was analyzed and relevant literature was reviewed. Result: Within 15 days of continuous intravenous use of ceftriaxone (2 g/d), the patient accidentally developed gallstones during chest CT examination during pulmonary infection. Because of the patient had no digestive symptoms, she stopped using ceftriaxone for 1 month. The gallstones disappeared during abdominal ultrasound examination. Conclusion: The incidence of pseudo-gallstones caused by ceftriaxone is relatively high, often seen in high-dose and long-term use. Most patients have no symptoms, as gallstones can disappear on their own within 1~2 months and generally do not require special treatment.
文章引用：陈力, 顾鹏. 一例头孢曲松诱导的假性胆囊结石及相关文献复习[J]. 临床医学进展, 2024, 14(6): 1296-1301. https://doi.org/10.12677/acm.2024.1461912

参考文献

[1] Schaad, U.B., Tschäppeler, H. and Lentze, M.J. (1986) Transient Formation of Precipitations in The Gallbladder Associated with Ceftriaxone Therapy. Pediatric Infectious Disease, 5, 708-709. [Google Scholar] [CrossRef] [PubMed]
[2] Jacobs, R.F. (1988) Ceftriaxone-Associated Cholecystitis. Pediatric Infectious Disease, 7, 434-435. [Google Scholar] [CrossRef] [PubMed]
[3] Ozturk, A., Kaya, M., Zeyrek, D., Ozturk, E., Kat, N. and Ziylan, S.Z. (2005) Ultrasonographic Findings in Ceftriaxone: Associated Biliary Sludge and Pseudolithiasis in Children. Acta Radiologica, 46, 112-116. [Google Scholar] [CrossRef] [PubMed]
[4] Acun, C., Erdem, L.O., Söğüt, A., et al. (2004) Gallbladder and Urinary Tract Precipitations Associated with Ceftriaxone Therapy in Children: A Prospective Study. Annals of Tropical Paediatrics, 24, 25-31. [Google Scholar] [CrossRef] [PubMed]
[5] Choi, Y.Y., Jung, Y.H., ChoI, S.M., Lee, C.S., Kim, D. and Hur, K.Y. (2011) Gallbladder Pseudolithiasis Caused By Ceftriaxone in Young Adult. Journal of the Korean Surgical Society, 81, 423-426. [Google Scholar] [CrossRef] [PubMed]
[6] Biner, B., Oner, N., Celtik, C., et al. (2006) Ceftriaxone-Associated Biliary Pseudolithiasis in Children. Journal of Clinical Ultrasound, 34, 217-222.
[7] Lee, S.P., Lipsky, B.A. and Teefey, S.A. (1990) Gallbladder Sludge and Antibiotics. The Pediatric Infectious Disease Journal, 9, 422-423. [Google Scholar] [CrossRef] [PubMed]
[8] Park, H.Z., Lee, S.P. and Schy, A.L. (1991) Ceftriaxone-Associated Gallbladder Sludge. Identification of Calcium-Ceftriaxone Salt as a Major Component of Gallbladder Precipitate. Gastroenterology, 100, 1665-1670. [Google Scholar] [CrossRef] [PubMed]
[9] 汪复, 张婴元. 实用抗感染治疗学[M]. 北京: 人民卫生出版社, 2020: 613.
[10] Stinton, L.M. and Shaffer, E.A. (2012) Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer. Gut Liver, 6, 172-187. [Google Scholar] [CrossRef] [PubMed]
[11] Martin, E., Fanconi, S., Kälin, P., et al. (1993) Ceftriaxone-Bilirubin-Albumin Interactions in the Neonate: An in Vivo Study. European Journal of Pediatrics, 152, 530-534. [Google Scholar] [CrossRef] 
[12] Arpacik, M., Ceran, C., Kaya, T., Karadas, B., Sarac, B. and Koyluoğlu, G. (2004) Effects of Ceftriaxone Sodium on in Vitro Gallbladder Contractility in Guinea Pigs. Journal of Surgical Research, 122, 157-161. [Google Scholar] [CrossRef] [PubMed]
[13] Araz, N., Okan, V., Demirci, M. and Araz, M. (2007) Pseudolithiasis Due to Ceftriaxone Treatment for Meningitis in Children: Report of 8 Cases. The Tohoku Journal of Experimental Medicine, 211, 285-290. [Google Scholar] [CrossRef] [PubMed]
[14] Ozturk, A., Kaya, M., Zeyrek, D., Ozturk, E., Kat, N. and Ziylan, S.Z. (2005) Ultrasonographic Findings in Ceftriaxone: Associated Biliary Sludge and Pseudolithiasis in Children. Acta Radiologica, 46, 112-116. [Google Scholar] [CrossRef] [PubMed]
[15] Meng, D., Cao, Y., Fu, J., Chen, R., Lu, L. and Tu, Y. (2010) Sonographic Assessment of Ceftriaxone-Associated Biliary Pseudolithiasis in Chinese Children. Journal of International Medical Research, 38, 2004-2010. [Google Scholar] [CrossRef] [PubMed]
[16] Fretzayas, A., Liapi, O., Papadopoulou, A., Nicolaidou, P. and Stamoulakatou, A. (2011) Is Ceftriaxone-Induced Biliary Pseudolithiasis Influenced by UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms? Case Reports in Medicine, 2011, Article ID: 730250. [Google Scholar] [CrossRef] [PubMed]
[17] Soysal, A., Eraşov, K., Akpinar, I. and Bakir, M. (2007) Biliary Precipitation during Ceftriaxone Therapy: Frequency and Risk Factors. The Turkish Journal of Pediatrics, 49, 404-407.
[18] Acun, C., Erdem, L.O., Sogut, A., Erdem, C.Z., Tomac, N. and Gundogdu, S. (2004) Ceftriaxone-Induced Biliary Pseudolithiasis and Urinary Bladder Sludge. Pediatrics International, 46, 368-370. [Google Scholar] [CrossRef] [PubMed]
[19] Rivera, M., GarcÍA-Herrera, A.L., Burguera, V., Sosa-Barrios, H., Palomares, J.R. and Quereda, C. (2011) Ceftriaxone-Associated Gallbladder Pseudolithiasis in a PD Patient. Peritoneal Dialysis International, 31, 97-99. [Google Scholar] [CrossRef] [PubMed]
[20] 相龙彬. 头孢曲松钠导致假性胆石症二例[J]. 中华放射学杂志, 2007, 41(10): 1150.
[21] Ozturk, A., Kaya, M., Zeyrek, D., Ozturk, E., Kat, N. and Ziylan, S.Z. (2005) Ultrasonographic Findings in Ceftriaxone: Associated Biliary Sludge and Pseudolithiasis in Children. Acta Radiologica, 46, 112-116. [Google Scholar] [CrossRef] [PubMed]
[22] Palanduz, A., Yalçin, I., Tonguç, E., et al. (2000) Sonographic Assessment of Ceftriaxone-Associated Biliary Pseudolithiasis in Children. Journal of Clinical Ultrasound, 28, 166-168. [Google Scholar] [CrossRef] 
[23] Papadopoulou, F., Efremidis, S., Karyda, S., et al. (1999) Incidence of Ceftriaxone-Associated Gallbladder Pseudolithiasis. Acta Paediatrica, 88, 1352-1355. [Google Scholar] [CrossRef] 
[24] Kirejczyk, W.M., Crowe, H.M., Mackay, I.M., Quintiliani, R. and Cronin, E.B. (1992) Disappearing “Gallstones”: Biliary Pseudolithiasis Complicating Ceftriaxone Therapy. American Journal of Roentgenology, 159, 329-330. [Google Scholar] [CrossRef] [PubMed]
[25] Bor, O., Dinleyici, E.C., Kebapci, M. and Aydogdu, S.D. (2004) Ceftriaxone-Associated Biliary Sludge and Pseudocholelithiasis during Childhood: A Prospective Study. Pediatrics International, 46, 322-324. [Google Scholar] [CrossRef] [PubMed]
[26] Akl, K.F., Masri, A.T. and Hjazeen, M.M. (2011) Acute Urineretention Induced by Ceftriaxone. Saudi Journal of Kidney Diseases and Transplantation, 22, 1226-1228.
[27] Li, Z.L., Li, H.L., Chen, H.W., et al. (2013) Anuria and Abdominal Pain Induced by Ceftriaxoneassociated Ureterolithiasis in Adults. International Urology and Nephrology, 45, 73-76. [Google Scholar] [CrossRef] [PubMed]
[28] Kapur, G., Valentini, R.P., Mattoo, T.K., Warrier, I. and Imam, A.A. (2008) Ceftriaxone Induced Hemolysiscomplicated by Acute Renal Failure. Pediatric Blood & Cancer, 50, 139-142. [Google Scholar] [CrossRef] [PubMed]
[29] Ito, R., Yoshida, A., Taguchi, K., Enoki, Y., Yokoyama, Y. and Matsumoto, K. (2019) Experimental Verification of Factors Influencing Calcium Salt Formation Based on a Survey of the Development of Ceftriaxone-Induced Gallstone-Related Disorder. Journal of Infection and Chemotherapy, 25, 972-978. [Google Scholar] [CrossRef] [PubMed]

为你推荐